Market Research Logo

Mymetics Corporation (MYMX) - Financial and Strategic SWOT Analysis Review

Mymetics Corporation (MYMX) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Mymetics Corporation (Mymetics) is a development stage biotechnology company which develops next-generation prophylactic vaccines for infectious diseases. It develops mucosal and virosomes based vaccines that help prevent HIV (AIDS) from crossing the mucosal barriers; malaria; respiratory syncytial virus (RSV); and influenza. Its vaccines are designed to induce protection against early transmission and infection. The company's product pipeline includes five vaccine candidates target HIV-1/AIDS, intra nasal Influenza, malaria, herpes simplex virus (HSV) and respiratory syncitial virus (RSV). The company and its subsidiaries have operations across Luxembourg, the US, Netherlands, and Switzerland. The company has partnerships with leading pharmaceutical or research organizations, including Astellas Pharma, PATH-MVI and the Bill and Melinda Gates Foundation. Mymetics is headquartered in Epalinges, Switzerland.

Mymetics Corporation Key Recent Developments

Nov 13, 2015: Mymetics Reports Q3 2015 Results
Aug 14, 2015: Mymetics Reports Q2 2015 Results
May 13, 2015: Mymetics Reports Q1 2015 Results
Apr 20, 2015: Mymetics-Led Consortium Awarded €8.4 Million for Development of Thermo Stable and Cold-Chain Independent Vaccines
Mar 10, 2015: Mymetics Reports 2014 Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Mymetics Corporation - Key Facts
Mymetics Corporation - Key Employees
Mymetics Corporation - Key Employee Biographies
Mymetics Corporation - Major Products and Services
Mymetics Corporation - Pharmaceutical Pipeline Products Data
Mymetics Corporation, Pipeline Products by Therapy Area
Mymetics Corporation, Pipeline Products by Development Phase
Mymetics Corporation - History
Mymetics Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Mymetics Corporation - Business Description
Mymetics Corporation - Corporate Strategy
Mymetics Corporation - SWOT Analysis
SWOT Analysis - Overview
Mymetics Corporation - Strengths
Strength - Innovative Product Development Approach
Strength - Intellectual Property
Strength - Sturdy Research and Development Activities
Mymetics Corporation - Weaknesses
Weakness - History of Losses
Weakness - Termination of Agreement with RSVC
Mymetics Corporation - Opportunities
Opportunity - Focus on HIV Treatment Market
Opportunity - Collaboration with PATH Malaria Vaccine Initiative
Mymetics Corporation - Threats
Threat - Governmental Regulations
Threat - Tightening FDA’s Regulations
Threat - Uncertain R&D Outcomes
Mymetics Corporation - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Mymetics Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Mymetics Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Mymetics Corporation, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 13, 2015: Mymetics Reports Q3 2015 Results
Aug 14, 2015: Mymetics Reports Q2 2015 Results
May 13, 2015: Mymetics Reports Q1 2015 Results
Apr 20, 2015: Mymetics-Led Consortium Awarded €8.4 Million for Development of Thermo Stable and Cold-Chain Independent Vaccines
Mar 10, 2015: Mymetics Reports 2014 Results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Mymetics Corporation, Key Facts
Mymetics Corporation, Key Employees
Mymetics Corporation, Key Employee Biographies
Mymetics Corporation, Major Products and Services
Mymetics Corporation, Number of Pipeline Products by Therapy Area
Mymetics Corporation, Number of Pipeline Products by Development Stage
Mymetics Corporation, Pipeline Products By Therapy Area and Development Phase
Mymetics Corporation, History
Mymetics Corporation, Subsidiaries
Mymetics Corporation, Key Competitors
Mymetics Corporation, Ratios based on current share price
Mymetics Corporation, Annual Ratios
Mymetics Corporation, Interim Ratios
Mymetics Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Mymetics Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Mymetics Corporation, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Mymetics Corporation, Pipeline Products by Therapy Area
Mymetics Corporation, Pipeline Products by Development Phase
Mymetics Corporation, Performance Chart (2011 - 2015)
Mymetics Corporation, Ratio Charts
Mymetics Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Mymetics Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report